Cruciferous vegetables may help reverse kidney damage in diabetes
It is estimated that about one-quarter of people with diabetes will eventually develop diabetic nephropathy, a gradual loss of kidney function eventually requiring dialysis.
The...
Common eye diseases and conditions in older people
The following eye problems can lead to vision loss and blindness in older adults. They may have few or no early symptoms.
Regular eye exams...
9 out of 10 patients with high blood pressure may need more treatment
In several recent studies from the University of Gothenburg, researchers found that many people with high blood pressure may need to get more treatment.
High...
Diabetes drugs may benefit lots of people with heart failure
In a study from Brigham and Women's Hospital, scientists found that drugs originally developed to treat type 2 diabetes may benefit a wide range...
Green tea and coffee linked to lower death risk in people with diabetes
In a study from Kyushu University, scientists found that drinking plenty of both green tea and coffee is linked to a lower risk of...
The first Omicron-adapted COVID-19 boosters are coming
There has been a lot of discussion in the media about Omicron-adapted COVID-19 boosters, which are undergoing regulatory approval in several countries.
The new booster...
1 in 3 older COVID survivors get new diseases after infection
In a study from Optum Labs in Minnetonka, scientists found almost a third (32 of every 100) of older adults infected with COVID-19 developed...
Monkeypox: What you should know
You may have heard that an outbreak of monkeypox is spreading across the country.
The virus got its name because it was first discovered in...
Protein in blood is sign of heart damage after surgery
Scientists from Linköping University in Sweden found after being anesthetized and undergoing major surgery, up to one in five patients have increased levels of...
New omicron BA.2.75 is not more resistant to antibodies
In a study from Karolinska Institutet, scientists found that BA.2.75 is not more resistant to antibodies than the currently dominating BA.5.
In May 2022, a...